SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000849146-24-000017
Filing Date
2024-01-30
Accepted
2024-01-30 16:05:56
Documents
16
Period of Report
2024-01-30
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lfvn-20240130.htm   iXBRL 8-K 28031
2 EX-99.1 earningsrelease_q2fy24.htm EX-99.1 260676
6 logoa18a.jpg GRAPHIC 6462
  Complete submission text file 0000849146-24-000017.txt   447342

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lfvn-20240130.xsd EX-101.SCH 1926
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lfvn-20240130_lab.xml EX-101.LAB 25156
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lfvn-20240130_pre.xml EX-101.PRE 13066
17 EXTRACTED XBRL INSTANCE DOCUMENT lfvn-20240130_htm.xml XML 2798
Mailing Address 3300 TRIUMPH BLVD SUITE 700 LEHI UT 84043
Business Address 3300 TRIUMPH BLVD SUITE 700 LEHI UT 84043 801-432-9000
Lifevantage Corp (Filer) CIK: 0000849146 (see all company filings)

IRS No.: 900224471 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-35647 | Film No.: 24578188
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)